Repeated analysis of semen parameters in beagle dogs during a 2-year study with the HMG-CoA reductase inhibitor, atorvastatin

Toxicological Sciences

Volumn 61, Issue 1, 2001, Pages 128-134

  Dostal, Lori A ^a   Juneau, Paul ^a   Rothwell, Charles E ^a  

^a PFIZER INC   (United States)

Author keywords

Atorvastatin; HMG CoA reductase inhibitor; Male beagle dogs; Semen analysis; Sperm analysis; Sperm motility

Indexed keywords

ATORVASTATIN; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; CALCULATION; CELL STRUCTURE; CHOLESTEROL BLOOD LEVEL; COLOR; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOG; EPIDIDYMIS; EUTHANASIA; EVALUATION; HISTOPATHOLOGY; MALE; MALE GENITAL SYSTEM; METHODOLOGY; NONHUMAN; ORGAN WEIGHT; PARAMETER; PROSTATE; RAT; REPRODUCTIVE TOXICITY; RODENT; SAMPLE; SEMEN ANALYSIS; SPERM; SPERMATOZOON COUNT; SPERMATOZOON DENSITY; SPERMATOZOON MOTILITY; STATISTICAL ANALYSIS; TESTIS; TIME; TOXICITY;

ACYL COENZYME A; ANIMALS; CHOLESTEROL; DOGS; EJACULATION; EPIDIDYMIS; HEPTANOIC ACIDS; MALE; ORGAN SIZE; PROSTATE; PYRROLES; SEMEN; SPERM COUNT; SPERM MOTILITY; SPERMATOZOA; TESTIS; TIME FACTORS;

ANIMALIA; CANIS FAMILIARIS; RODENTIA;

EID: 0035041067     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/61.1.128     Document Type: Article

References (25)

1. Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia
2. Manual for breeding soundness examination of bulls
3. Effects of long-term pravastatin treatment on spermatogenesis and on adrenal and testicular steroidogenesis in male hypercholesterolemic patients
4. Andrology of the normal male
5. Effects of simvastatin and pravastatin on gonadal function in male hypercholesterolemic patients
6. Long-term endocrine function in hypercholesterolemic patients treated with pravastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor
7. Fertility and general reproduction studies in rats with the HMG-CoA reductase inhibitor, atorvastatin
8. Testicular function in Type-II hyperlipoproteinemic patients treated with lovastatin (mevinolin) or neomycin
9. Clinical evaluation of infertility in dogs
10. Animal safety and toxicology of simvastatin and related hydroxy-methylglutaryl-coenzyme A reductase inhibitors
11. Performing a complete canine semen evaluation in a small animal hospital
12. Preclinical evaluation of lovastatin. Am
13. Semen quality after thawing: Correlation with fertility and fresh semen quality in dogs
14. Sperm morphology and fertility in the dogs
15. Sperm abnormalities in the dog: A light and electron microscopic study
16. Relationships among testicular size, daily production, and output of spermatozoa, and extragonadal spermatozoal reserves of the dog
17. Nonparametric sequential trend test. Proc
18. Guidelines for using the canine breeding soundness evaluation form
19. Short-term effects of treatment with simvastatin on testicular function in patients with heterozygous familial hypercholesterolaemia
20. Simvastatin influences testicular steroidogenesis in human
21. Collection and evaluation of canine semen
22. The effect of the frequency of ejaculation on seminal characteristics and libido in the Beagle dog
23. Sustained therapy with 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitors does not impair steroidogenesis by adrenals and gonads
24. Testing the statistical certainty of a response to increasing doses of a drug
25. Hepatic effects in beagle dogs administered atorvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, for 2 years